Mode
Text Size
Log in / Sign up

Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infectionPremature birth and wheezing raise severe HMPV pneumonia risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that HMPV infection is associated with higher risks of severe CAP, wheezing, and specific biomarkers in hospitalized children.

A retrospective cohort study analyzed data from 878 hospitalized children with human metapneumovirus (HMPV)-positive community-acquired pneumonia (CAP) at Shanghai Children's Hospital. The researchers compared patients with severe CAP to those with mild CAP to identify independent risk factors associated with disease severity.

The study found that 28.0% of the cohort had severe disease, with 246 severe cases and 632 mild cases. Premature birth was significantly higher in the severe group, with an odds ratio of 2.43 and a 95% CI of 1.45–4.07. Wheezing was also significantly higher in the severe group, with an odds ratio of 3.47 and a 95% CI of 2.51–4.80.

Additional markers significantly higher in the severe group included NLR > 1 (OR = 1.75, 95% CI: 1.26–2.43), PCT > 1 ng/mL (OR = 2.38, 95% CI: 1.42–3.99), CRP ≥ 50 mg/L (OR = 2.20, 95% CI: 1.19–4.06), and co-infection with Mycoplasma pneumoniae (OR = 2.17, 95% CI: 1.53–3.08). Multivariate analysis identified these as independent risk factors.

The study design is observational, which means associations do not prove causation. No specific adverse events or discontinuations were reported in the safety data. These results can facilitate early risk stratification and targeted clinical management for pediatric patients with HMPV infection.

A new study from Shanghai Children's Hospital looked at 878 children hospitalized with human metapneumovirus (HMPV) pneumonia. About 28% of them had severe disease. Researchers wanted to find out which children were most likely to become severely ill.

The study found that children born prematurely were more than twice as likely to develop severe pneumonia. Those who had wheezing were over three times as likely. Other risk factors included certain lab markers like high neutrophil-to-lymphocyte ratio (NLR), high procalcitonin (PCT), and high C-reactive protein (CRP). Co-infection with Mycoplasma pneumoniae also raised the risk.

This was a retrospective study, meaning researchers looked back at medical records. It cannot prove that these factors cause severe disease, only that they are linked. The study was done at one hospital in China, so results may not apply to all children everywhere.

For parents and doctors, these findings can help identify children with HMPV pneumonia who may need closer monitoring. If a child was born early or has wheezing, they may be at higher risk for severe illness. But more research is needed to confirm these results in other settings.

What this means for you:
Premature birth and wheezing are linked to higher risk of severe HMPV pneumonia in children.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
HMPV is a leading cause of pediatric lower respiratory tract infections, second only to respiratory syncytial virus in causing severe pneumonia in children. Its clinical presentation closely mimics other common respiratory viruses, making diagnosis challenging. This study aimed to characterize the clinical profile and identify independent risk factors for severe community-acquired pneumonia (CAP) in hospitalized children with human metapneumovirus (HMPV) infection. We conducted a retrospective cohort study of 878 children hospitalized with HMPV-positive CAP at Shanghai Children’s Hospital from 2021 to 2024. Patients were classified into mild (n = 632) and severe (n = 246) groups based on established CAP criteria. Data on demographics, clinical features, laboratory findings, and concomitant pathogen detection were collected. Multivariate logistic regression was used to identify independent risk factors for severe disease. The severe group comprised 28.0% of the cohort. Key clinical manifestations included fever (98.0%), cough (97.6%), wheezing (56.5%), and pulmonary crackles (84.6%). Compared to the mild group, the severe group had significantly higher rates of premature birth, wheezing, elevated inflammatory markers (NLR > 1, PCT > 1 ng/mL, CRP ≥ 50 mg/L), and co-infection with Mycoplasma pneumoniae (MP) (all P < 0.05). Multivariate analysis identified premature birth (odds ratio [OR] = 2.43, 95% CI: 1.45–4.07), wheezing (OR = 3.47, 95% CI: 2.51–4.80), NLR > 1 (OR = 1.75, 95% CI: 1.26–2.43), PCT > 1 ng/mL (OR = 2.38, 95% CI: 1.42–3.99), CRP ≥ 50 mg/L (OR = 2.20, 95% CI: 1.19–4.06), and co-infection with MP (OR = 2.17, 95% CI: 1.53–3.08) as independent risk factors for severe CAP in children with HMPV infection. Approximately 28% of hospitalized children with HMPV-positive CAP progress to severe disease. Premature birth, wheezing, elevated inflammatory markers, and co-infection with MP are independent risk factors, which can facilitate early risk stratification and targeted clinical management.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.